IGC Pharma, Inc. (IGC)
0.3195
+0.01
(+3.83%)
USD |
NYAM |
Aug 27, 09:42
IGC Pharma Debt to Equity Ratio : 0.1765 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1765 |
| March 31, 2026 | 0.1513 |
| December 31, 2025 | 0.0195 |
| September 30, 2025 | 0.0185 |
| June 30, 2025 | 0.0337 |
| March 31, 2025 | 0.0381 |
| December 31, 2024 | |
| September 30, 2024 | 0.0416 |
| June 30, 2024 | 0.0433 |
| March 31, 2024 | 0.0475 |
| December 31, 2023 | 0.042 |
| September 30, 2023 | 0.0296 |
| June 30, 2023 | 0.0342 |
| March 31, 2023 | 0.0325 |
| December 31, 2022 | 0.0281 |
| September 30, 2022 | 0.0272 |
| June 30, 2022 | 0.0206 |
| March 31, 2022 | 0.0204 |
| December 31, 2021 | 0.0177 |
| September 30, 2021 | 0.0177 |
| June 30, 2021 | 0.0184 |
| March 31, 2021 | 0.03 |
| December 31, 2020 | 0.051 |
| September 30, 2020 | 0.0473 |
| June 30, 2020 | 0.0477 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0202 |
| December 31, 2019 | 0.0017 |
| September 30, 2019 | 0.0016 |
| June 30, 2019 | 0.0015 |
| March 31, 2019 | 0.0015 |
| December 31, 2018 | 0.0018 |
| September 30, 2018 | 0.1467 |
| June 30, 2018 | 0.2674 |
| March 31, 2018 | 0.2762 |
| December 31, 2017 | 0.339 |
| September 30, 2017 | 0.4094 |
| June 30, 2017 | 0.3874 |
| March 31, 2017 | 0.3593 |
| December 31, 2016 | 0.3801 |
| September 30, 2016 | 0.1958 |
| June 30, 2016 | 0.1941 |
| March 31, 2016 | 0.2092 |
| December 31, 2015 | 0.2282 |
| September 30, 2015 | 0.229 |
| June 30, 2015 | 0.2742 |
| March 31, 2015 | 0.2443 |
| December 31, 2014 | 0.2143 |
| September 30, 2014 | 0.2218 |
| June 30, 2014 | 0.1987 |
| March 31, 2014 | 0.1633 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.496M |
| Total Liabilities (Quarterly) | 3.364M |
| Shareholders Equity (Quarterly) | 6.132M |
| Current Ratio | 0.3932 |
| Net Debt Paydown Yield | -0.60% |